SABS - SAB Biotherapeutics Inc
3.79
-0.020 -0.528%
Share volume: 155,952
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$3.81
-0.02
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-20-2024 | 08-08-2024 | 11-06-2024 | 05-09-2025 | 11-13-2025 | |
| Cash flow financing | -394.418 K | -321.039 K | -674.130 K | -173.985 K | 168.689 M | |
| Other financing cash flows | 0.000 | -101.390 K | -58.312 K | -36.690 K | 168.689 M | |
| Cash flow | -10.750 M | 3.180 M | -8.119 M | -3.300 M | 25.770 M | |
| Net income | -5.026 M | -7.335 M | -10.349 M | -5.197 M | 45.445 M | |
| Depreciation | 1.985 M | 1.034 M | 945.154 K | 756.595 K | 743.764 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 193.232 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -31.359 M | 11.219 M | -1.153 M | 4.671 M | -129.869 M | |
| Net Borrowings | -41.307 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -129.074 K | 52.511 K | 100.300 K | -500.000 | 0.000 | |
| Cash Change | 44.057 M | 3.208 M | -8.071 M | -3.258 M | 25.732 M |